20.09.2012 • NewsBPBP RussiaRussia

BP Would Get Rosneft Stake in TNK-BP Deal

BP is in talks with Rosneft that may result in the British oil major acquiring at least 12.5% of the Russian state oil firm, the Kommersant financial daily reported on Thursday, citing sources close to the two companies.

BP's acquisition of Rosneft shares would take place as part of a deal under discussion to sell BP's 50% stake in Anglo-Russian oil venture TNK-BP, Russia's No.3 oil firm.

Rosneft is looking at buying 25% of TNK-BP's shares for $10-$15 billion in cash, with another 25% to be acquired with Rosneft shares, Kommersant wrote.

It also reported that Rosneft planned to use treasury shares representing 9.53% of its equity, as well as shares acquired in a recent buy-back, worth just over 3% of its equity.

Rosneft declined immediate comment on the Kommersant report.

Bankers told Reuters on Wednesday that Rosneft is talking to foreign banks about raising $15 billion in debt financing. A further $5 billion could be raised from Russian banks, one banker also said.

The details published in Kommersant follow a meeting on Tuesday between President Vladimir Putin, Rosneft CEO Igor Sechin, BP's Chief Executive Robert Dudley and Chairman Carl-Henric Svanberg.

Sources close to both companies said on Wednesday that talks were progressing but played down expectations of an imminent breakthrough.

The co-owners of TNK-BP, a quartet of Soviet-born tycoons represented by the AAR consortium, have also expressed interest in buying 25% of the company from BP for $10 billion, but talks have stalled, sources familiar with the matter say.

Under a shareholders agreement, third parties may not strike a deal to buy BP's stake in TNK-BP before a mid-October deadline expires.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.